Final reports from 13th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 February 2006, Denver
12 May 2006. Related: Conference reports , Conference index, CROI 13 (Retrovirus) 2006
HIV Treatment Bulletin
CROI 13 (Retrovirus) 2006
Regimen durability and toxicity in 36-month follow up on ART in Khayelitsha, South Africa
12 May 2006. Related: Conference reports, Side effects , CROI 13 (Retrovirus) 2006
Adults in resource-limited settings are most likely to experience an HIV-associated Illness in the first three months from initiating therapy
12 May 2006. Related: Conference reports , CROI 13 (Retrovirus) 2006
Causes of death in adults receiving ARV therapy in Senegal
12 May 2006. Related: Conference reports , CROI 13 (Retrovirus) 2006
Rapid scale-up of treatment in Zambia delivered at primary health level
12 May 2006. Related: Conference reports , CROI 13 (Retrovirus) 2006
The effect of HIV subtype on disease progression in Rakai, Uganda
12 May 2006. Related: Conference reports , CROI 13 (Retrovirus) 2006
Genital tract pharmacokinetics of ten antiretroviral drugs in HIV-positive women
12 May 2006. Related: Conference reports, Women's health , CROI 13 (Retrovirus) 2006
Initiation of ART leads to a rapid decline in cervical and vaginal HIV-1 RNA
12 May 2006. Related: Conference reports, Women's health , CROI 13 (Retrovirus) 2006
Effect of HSV-2 treatment on HIV-1 genital shedding and plasma viral load
12 May 2006. Related: Conference reports, Women's health , CROI 13 (Retrovirus) 2006
Once-daily FTC, ddI, and efavirenz in children and adolescents
12 May 2006. Related: Conference reports, Paediatric care , CROI 13 (Retrovirus) 2006
Simplified triple NRTI regimen effective in vertically infected children: two years follow-up
12 May 2006. Related: Conference reports, Paediatric care , CROI 13 (Retrovirus) 2006
Long-term clinical and biological outcomes in children vertically infected with HIV
12 May 2006. Related: Conference reports, Paediatric care , CROI 13 (Retrovirus) 2006
Prospective follow up of children with lipodystrophy
12 May 2006. Related: Conference reports, Paediatric care , CROI 13 (Retrovirus) 2006
Tuberculosis in HIV-positive children often missed from incidence data: the influence of HAART on paediatric TB
12 May 2006. Related: Conference reports, Paediatric care, TB coinfection , CROI 13 (Retrovirus) 2006
Nevirapine pharmacokinetics with infant prophylaxis
12 May 2006. Related: Conference reports, Paediatric care , CROI 13 (Retrovirus) 2006
Prevention of rectal transmission of SIV in macaques using FTC with tenofovir: FTC has independent protective effect even as monotherapy
12 May 2006. Related: Conference reports, Transmission and prevention , CROI 13 (Retrovirus) 2006
K65R frequently emerges within 1-6 weeks of tenofovir monotherapy in macaques
12 May 2006. Related: Conference reports, Transmission and prevention , CROI 13 (Retrovirus) 2006
A genome armed against HIV
12 May 2006. Related: Conference reports, Transmission and prevention , CROI 13 (Retrovirus) 2006
Circumcision: a surprising benefit from an unkind cut
12 May 2006. Related: Conference reports, Transmission and prevention , CROI 13 (Retrovirus) 2006
Topical microbicides: the real front line of HIV prevention
12 May 2006. Related: Conference reports, Transmission and prevention, Vaccines and microbicides , CROI 13 (Retrovirus) 2006
Prevention of rectal transmission of SIV in macaques using FTC with tenofovir: FTC has independent protective effect even as monotherapy
3 May 2006. Related: Conference reports , CROI 13 (Retrovirus) 2006
Further reports from 13th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 February 2006, Denver
13 April 2006. Related: Conference reports , Conference index, CROI 13 (Retrovirus) 2006
Pharmacokinetics of antiretrovirals in pregnancy: tenofovir, nelfinavir, lopinavir/r
13 April 2006. Related: Conference reports, PMTCT and maternal health , CROI 13 (Retrovirus) 2006
Risk of central nervous system birth defects associated with ART exposure during pregnancy
13 April 2006. Related: Conference reports, PMTCT and maternal health , CROI 13 (Retrovirus) 2006
No increase in adverse pregnancy outcomes in Thai women receiving nevirapine-containing HAART
13 April 2006. Related: Conference reports, PMTCT and maternal health , CROI 13 (Retrovirus) 2006
ARV treatment following singe dose nevirapine exposure
13 April 2006. Related: Conference reports, Women's health , CROI 13 (Retrovirus) 2006
Association of HIV replication capacity with mother to child transmission
13 April 2006. Related: Conference reports, PMTCT and maternal health , CROI 13 (Retrovirus) 2006
Association between HIV subtype and detection of K103N
13 April 2006. Related: Conference reports, PMTCT and maternal health, Resistance , CROI 13 (Retrovirus) 2006
Pharmacology and drug interaction studies in adults: summary table from CROI, ICAAC and EACS conferences
12 April 2006. Related: Conference reports, PK and drug interactions , CROI 13 (Retrovirus) 2006, EACS 10 Dublin 2005, ICAAC 45th Washingon 2005
Other new antiretrovirals at Denver: the future seems bright
12 April 2006. Related: Antiretrovirals, Conference reports , CROI 13 (Retrovirus) 2006
Origins of HIV traced to chimpanzees in Cameroon
12 April 2006. Related: Conference reports , CROI 13 (Retrovirus) 2006
HSV-2 suppression reduces HIV and HSV shedding
12 April 2006. Related: Conference reports, Transmission and prevention , CROI 13 (Retrovirus) 2006
13th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 February 2006, Denver
26 March 2006. Related: Conference reports , Conference index, CROI 13 (Retrovirus) 2006
Early integrase inhibitor studies in treatment experienced patients raise hopes for new drugs in a new class
25 March 2006. Related: Antiretrovirals, Conference reports , CROI 13 (Retrovirus) 2006
Atazanavir in treatment naive patients, with and without ritonavir boosting
25 March 2006. Related: Antiretrovirals, Conference reports , CROI 13 (Retrovirus) 2006
Simplification to atazanavir/ritonavir monotherapy
25 March 2006. Related: Conference reports, Treatment strategies , CROI 13 (Retrovirus) 2006
Summary of STI studies: SMART shows clear increased risk from interrupting treatment at any CD4 count
25 March 2006. Related: Conference reports, Treatment strategies , CROI 13 (Retrovirus) 2006
The effect of repeated single-dose nevirapine for PMTCT in a second pregnancy
25 March 2006. Related: Conference reports, PMTCT and maternal health , CROI 13 (Retrovirus) 2006
Should criteria for initiation of HAART be revisited in pregnant women?
25 March 2006. Related: Conference reports, PMTCT and maternal health , CROI 13 (Retrovirus) 2006
Cotrimoxazole prophylaxis in pregnancy
25 March 2006. Related: Conference reports, PMTCT and maternal health , CROI 13 (Retrovirus) 2006
Treatment in primary HIV infection
25 March 2006. Related: Conference reports, Treatment strategies , CROI 13 (Retrovirus) 2006
CNS penetration of ARV drugs is associated with lower CSF viral load
25 March 2006. Related: Antiretrovirals, Conference reports , CROI 13 (Retrovirus) 2006
Sexual transmission of hepatitis C in HIV-positive men in the UK
25 March 2006. Related: Conference reports, Hepatitis coinfection , CROI 13 (Retrovirus) 2006
D:A:D study shows that PIs rather than NNRTIs drive the previously reported cardiovascular risk of combination antiretroviral therapy
25 March 2006. Related: Conference reports, Side effects , CROI 13 (Retrovirus) 2006
Interventions for the management of lipodystrophy and metabolic complications
25 March 2006. Related: Conference reports, Lipodystrophy and metabolic complications, Side effects , CROI 13 (Retrovirus) 2006